Surpass-ET Trial: A Phase 3, Open-Label, Multicenter, Randomized, Active-Controlled Study to Assess Pharmacokinetics and Compare the Efficacy, Safety, and Tolerability of P1101 Vs Anagrelide As Second Line Therapy for Essential Thrombocythemia
| Autor: | Mesa, Ruben A., Komatsu, Norio, Gill, Harinder, Jin, Jie, Lee, Sung-Eun, Hou, Hsin-An, Sato, Toshiaki, Qin, Albert, Urbanski, Raymond, Shih, Weichung, Zagrijtschuk, Oleh, Zimmerman, Craig, Verstovsek, Srdan |
|---|---|
| Zdroj: | Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p1491-1491, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|